Circulating Tumor Cells - Global Market Outlook (2015-2022)

February 2016 | 132 pages | ID: C735AE50EB5EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Circulating Tumor Cells Market is accounted for $4.41 billion in 2015 and is expected to reach $17.96 billion by 2022 growing at a CAGR of 19.2 % from 2015 to 2022. The rising demand for high Benefit-Cost Ratio (BCR) associated with CTCs prognostic technology is the major factor boosting the market growth. Furthermore, advancements in biomedical imaging and bioengineering technology are some of the key factors driving the market. However, high cost associated with the diagnosing and reluctance among people towards adopting highly developed prognostic technologies inhibit the market growth. The recent trends in global Circulating Tumor Cells are strengthening distribution network of CTCs prognostic technologies in emerging economies and the technical advancement of CTCs-based customized medicines.

Tumor cell detection is the foremost product segment primarily due to the advantages related with therapeutic monitoring and high procedure prices. North America region is expected to witness highest growth rate during the forecast period due to increasing demand in number of research projects. In addition, the U.S. Government also supports research by funding various institutes, which grant research funds.

Some of the key players in the market include Adnagen AG, Advanced Cell Diagnostics, Apocell, Aviva Biosciences, Biocep Ltd., Biocept Inc., Biofluidica, Canopus Biosciences, CellTraffix Inc., Clearbridge BioMedics, Creatv Microtech Inc., Cynvenio Biosystems Inc. , Epic Biosciences, Fluxion Biosciences., Greiner Bio-One GmbH, Ikonisys Inc., IV Diagnostics Inc., Janssen Diagnostics, Miltenyi Biotech and Nanostring Technologies Inc.

Technologies Covered:

• Tumor Cell Enrichment
• Filtration
• Centrifugation
• Immunological and Immunomagnetic
• Tumor Cell Detection
• Molecular
• Optical

Applications Covered:

• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Other Applications

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL CIRCULATING TUMOR CELLS MARKET, BY TECHNOLOGY

5.1 Introduction
5.2 Tumor Cell Enrichment
  5.2.1 Filtration
  5.2.2 Centrifugation
  5.2.3 Immunological and Immunomagnetic
5.3 Tumor Cell Detection
  5.3.1 Molecular
  5.3.2 Optical

6 GLOBAL CIRCULATING TUMOR CELLS MARKET, BY APPLICATIONS

6.1 Introduction
6.2 Breast Cancer
6.3 Colorectal Cancer
6.4 Prostate Cancer
6.5 Other Applications

7 GLOBAL CIRCULATING TUMOR CELLS MARKET, BY GEOGRAPHY

7.1 North America
  7.1.1 US
  7.1.2 Canada
  7.1.3 Mexico
7.2 Europe
  7.2.1 Germany
  7.2.2 France
  7.2.3 Italy
  7.2.4 UK
  7.2.5 Spain
  7.2.6 Rest of Europe
7.3 Asia Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India
  7.3.4 Australia
  7.3.5 New Zealand
  7.3.6 Rest of Asia Pacific
7.4 Rest of the World
  7.4.1 Middle East
  7.4.2 Brazil
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt

8 KEY DEVELOPMENTS

8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 COMPANY PROFILING

9.1 Adnagen AG
9.2 Advanced Cell Diagnostics
9.3 Apocell
9.4 Aviva Biosciences
9.5 Biocep Ltd.
9.6 Biocept Inc.
9.7 Biofluidica
9.8 Canopus Biosciences
9.9 CellTraffix Inc.
9.10 Clearbridge BioMedics
9.11 Creatv Microtech Inc.
9.12 Cynvenio Biosystems Inc.
9.13 Epic Biosciences
9.14 Fluxion Biosciences.
9.15 Greiner Bio-One GmbH
9.16 Ikonisys Inc.
9.17 IV Diagnostics Inc.
9.18 Janssen Diagnostics
9.19 Miltenyi Biotech
9.20 Nanostring Technologies Inc.

List Of Tables

LIST OF TABLES

Global Circulating Tumor Cells Market Outlook, By Region (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Technology (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Applications (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Prostate Cancer (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Breast Cancer (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (201-2022) ($MN)
Global Circulating Tumor Cells Market Outlook, By Other Applications (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Technology (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (201-2022) ($MN)
1North America Circulating Tumor Cells Market Outlook, By Applications (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Prostate Cancer (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Breast Cancer (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (201-2022) ($MN)
North America Circulating Tumor Cells Market Outlook, By Other Applications (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Technology (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Applications (201-2022) ($MN)
2Europe Circulating Tumor Cells Market Outlook, By Prostate Cancer (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Breast Cancer (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (201-2022) ($MN)
Europe Circulating Tumor Cells Market Outlook, By Other Applications (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Technology (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Applications (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Prostate Cancer (201-2022) ($MN)
3Aisa Pacific Circulating Tumor Cells Market Outlook, By Breast Cancer (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (201-2022) ($MN)
Aisa Pacific Circulating Tumor Cells Market Outlook, By Other Applications (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Technology (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Applications (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Prostate Cancer (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Breast Cancer (201-2022) ($MN)
Rest of the World Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (201-2022) ($MN)
4Rest of the World Circulating Tumor Cells Market Outlook, By Other Applications (201-2022) ($MN)